SUN2 and prostate cancer: The aim of the present study was to examine the relationship between Sun2 expression and clinicopathologic outcomes by tissue microarray (TMA) of 90 prostate cancer patients, and then investigate the role of Sun2 in prostate cancer cell growth in vitro and in vivo.